Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
€0.07 - €0.91
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | - |
EV | - |
Shares Outstanding | - |
Beta | - |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €2.02 |
P/E 2024E | - |
P/Revenue 2024E | 1.07x |
Revenue | 2.00% |
EPS | 74.60% |
Operating Cash Flow | -17.80% |
Free Cash Flow | -39.70% |
Revenue | 107.00% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2024E | - |
Net Profit Margin 2024E | -717.01% |
ROE 2024E | -80.40% |
ROCE 2023 | -51.01% |
DPS 2024E | €0.00 |
Payout Ratio 2024E | 0.00% |
Div. Yield 2024E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
BenevolentAI S.A.
BAI
Sector
Healthcare
Industry
Biotechnology
CEO
Data Unavailable
Employees
Website
www.benevolent.comIPO Date
2022-04-25
Headquarters
4-8 Maple Street, London, Greater London, W1T 5HD, United Kingdom
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved